Trial Profile
Add-on effects of tadalafil for tamsulosin treated patients with benign prostatic hyperplasia suffering from residual lower urinary tract symptoms: a randomized, placebo-controlled, double-blind, crossover study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Dec 2019
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary)
- Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
- Focus Therapeutic Use
- 01 Jun 2019 Status changed from recruiting to completed.
- 05 Aug 2015 Status changed from not yet recruiting to recruiting as per University Hospital Medical Information Network - Japan.
- 09 Oct 2014 New trial record